China Meheco Group News

China Pharmaceuticals: Announcement on Subsidiaries Obtaining Drug Registration Approvals

Dec 5 00:00

China Pharmaceutical: 2024 Fifth Extraordinary General Meeting of Shareholders Meeting Information

Dec 5 00:00

Announcement on the subsidiary obtaining approval for drug registration

Dec 5 00:00

2024 Fifth Extraordinary General Meeting of Shareholders Meeting Materials

Dec 5 00:00

China Pharmaceutical: Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementary Applications

Dec 3 00:00

Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementation Applications

Dec 3 00:00

Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation

Nov 30 00:00

Announcement on the progress of important shareholding companies planning to change the actual controller

Nov 29 00:00

China Pharmaceutical Investor Relations Activity Record Form

Nov 28 11:30

Announcement of Resolutions of the 21st Meeting of the 9th Board of Directors

Nov 28 00:00

General Technology Liaoning Pharmaceutical Co., Ltd. 2023 Audit Report

Nov 28 00:00

Announcement on the acquisition of related-party assets

Nov 28 00:00

Announcement on renewal of office buildings and related transactions

Nov 28 00:00

General Technology Liaoning Pharmaceutical Co., Ltd. Shareholders\' Total Equity Value Asset Assessment Report

Nov 28 00:00

Related Party Fund Transaction Management System (2024 Revision)

Nov 28 00:00

Notice on the change of accounting firm

Nov 28 00:00

Notice on convening the 5th Extraordinary General Meeting of Shareholders in 2024

Nov 28 00:00

Announcement on the subsidiary obtaining approval for drug registration

Nov 22 00:00

Announcement on the subsidiary obtaining approval for drug registration

Nov 22 00:00

Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation

Nov 14 00:00